Invention Grant
- Patent Title: Imidazo(4,5-B) pyridin-2-yl amides as KV7 channel activators
-
Application No.: US14776271Application Date: 2014-03-17
-
Publication No.: US09650376B2Publication Date: 2017-05-16
- Inventor: Lynn Resnick , George T. Topalov , Steven A. Boyd , Justin K. Belardi , Charles A. Flentge , James S. Hale , Scott S. Harried , David A. Mareska , Kai Zhang , Charles R. Heap , Mark Hadden , Wenge Cui , Hélène Decornez , Shuang Liu
- Applicant: Knopp Biosciences LLC
- Applicant Address: US PA Pittsburgh
- Assignee: KNOPP BIOSCIENCES LLC
- Current Assignee: KNOPP BIOSCIENCES LLC
- Current Assignee Address: US PA Pittsburgh
- Agency: K&L Gates LLP
- Agent Louis C. Cullman; Robert W. Winn
- International Application: PCT/US2014/030686 WO 20140317
- International Announcement: WO2014/145852 WO 20140918
- Main IPC: C07D519/00
- IPC: C07D519/00 ; C07D471/04
Abstract:
Compounds represented by formula 1 can be potent and/or partially selective for the Kv7.2/7.3 heteromultimer. They may be useful in treating disorders related to seizures, pain, neurotransmitter release, etc.
Public/Granted literature
- US20160031875A1 IMIDAZO(4,5-B) PYRIDIN-2-YL AMIDES AS KV7 CHANNEL ACTIVATORS Public/Granted day:2016-02-04
Information query
